Posted on by ScienceFather
67 / 100
Powered by Rank Math SEO
SEO Score

Prof. Nemany Hanafy: Cancer Nanotechnology: Best Researcher Award

Prof. Nemany Hanafy, Nanoscience and Nanotechnology Institute, Egypt

👨‍🔬 Prof. Nemany Hanafy is an accomplished molecular cell biologist and nano-medicine researcher, currently serving as an Assistant Professor at the Nanoscience and Nanotechnology Institute, Kafrelsheikh University, Egypt. With expertise in drug delivery systems and a focus on lung cancer invasiveness, his recent ASRT project demonstrates his commitment to cutting-edge biotechnological solutions. Holding a Ph.D. in Physics and Nanoscience, his groundbreaking work includes multifunctional bio nano-engineered drug delivery systems. Prof. Hanafy’s extensive review contributions to top journals showcase his influence in the scientific community. 🧬🔬✨

🔬 Professional Experience:

Biotechnological ASRT Project: “Cisplatin loaded targeting delivery system as a promising strategy against invasiveness of lung cancer cells” (Under-reviewer, ASRT-2023). Ideation fund project on Corona: “Development aerosol inhibitor for corona protease cleavage based on mucoadhesive nanoparticles to improve respiratory mucus penetration” (ASRT, No.6841; 5/2020-5/2021). Researcher/Lecturer of Nano-medicine at Nanoscience and Nanotechnology Institute, Kafrelsheikh University, Egypt (03/2018 – up to date). Editorial roles: Reviewer for various high-impact journals and Review Editor for Nanobiotechnology at Frontiers.

👨‍🔬 Academic Achievements:

PhD in Physics and Nanoscience (2017), focused on multifunctional bio nano-engineered drug delivery systems for hepatocellular carcinoma cells. Master’s Degree in Cytochemistry and Histology (2011) with a research project on the effects of CCL4 on cytogenic content in rats. Active membership in the European Association for the Study of the Liver.

🏆 Awards and Recognitions:

Young Investigator Bursary registration at the International EASL conference 2016, Barcelona. Third EBTN Best Oral Presentation at Biotechnology Congress 2014. Marie Curie Fellowship scientific collaborator position at National Research Council Nanotechnology Institute.

📚 Education:

PhD (2014-2017) and Master’s Degree (2005-2011) from Al-Azhar University, with a focus on liver-related projects. Pre-Master’s Degree (2003) and Bachelor’s Degree (2000) in Biology/Zoology.

👨‍🏫 Employment History:

Scientific collaborator at the Nanotechnology Lab, National Research Council (CNR), Italy (2013-2016). Senior Lab at Kuwait University, focusing on Cell Biology and Histology (2006-2012).

🏅 Additional Achievements:

1st Prize for the best undergraduate student in the Department of Biology/Zoology in 2000. Hospital Clinical Di Bari Secondment in 2016.

Professional Profiles:

The impact of her research is evident in citation metrics and indices from Google Scholar:

  • Cited by: All – 1104.
  • Citations – 1104.
  • h-index – 18.
  • Documents – 77.

A prolific researcher making meaningful contributions to the academic world!

🔬 Research Focus:

Prof. Nemany Hanafy’s research focuses on the development of advanced drug delivery systems, particularly in the realm of nanoscience and nanotechnology. His work encompasses the design and optimization of micelles structures for smart cancer therapy, utilizing chitosan as a natural copolymer with unique hydrogel-forming properties. Additionally, his contributions include the exploration of muco-inhalable delivery systems for anti-inflammatory and anti-COVID-19 applications, employing Silymarin/curcumin-loaded albumin nanoparticles coated by chitosan. 🔬 Prof. Hanafy’s diverse portfolio extends to the development of mucoadhesive hydrogel nanoparticles as smart biomedical drug delivery systems, halloysite clay nanotubes as carriers for curcumin, and quercetin encapsulated chitosan-functionalized copper oxide nanoparticles as anti-breast cancer agents. He has also delved into the design of theranostic systems based on folic acids and chitosan for encapsulating curcumin against specific conditions. 🩺 His research addresses liver cancer treatment with mucoadhesive curcumin crosslinked carboxy methyl cellulose and explores innovative approaches such as inhibiting glycolysis using micro/nano-lipid bromopyruvic chitosan carriers for improved hepatocellular carcinoma treatment. Furthermore, Prof. Hanafy has investigated hybrid polymeric-protein nano-carriers for targeted delivery of TGFβ inhibitors to hepatocellular carcinoma cells. 🌐 With a significant impact, his work has garnered citations, reflecting the recognition and influence of his contributions in the field of nanomedicine and drug delivery. Prof. Hanafy’s research underscores a commitment to advancing therapeutic strategies with a focus on precision and innovation. 👨‍🔬🎯🌟

Publications Top Note:

Nemany Hanafy | Cancer Nanotechnology | Best Researcher Award

You May Also Like